Furthermore, in an independent xenograft mouse model, the combination of anti-PD-L1 and anti-CD73 therapy enhanced T cell-mediated killing of EGFRm NSCLC, whereas monotherapy with either antibody was ineffective [54]. Here, CD274 is linked to non-small cell lung carcinoma.